Navigation Links
Positive Results from Phase 2 Trial of Mesoblast's Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting
Date:11/14/2011

at 6 months, p=0.015) and improved functional capacity (gain of 52.6 meters over 6 minutes' walk compared with controls at 12 months, p=0.06).

After 12 months, 40% of all treated patients had reverted to class I NYHA status compared with 14% of all controls, and this effect remained when patients were matched for the presence of class II status at baseline. The group who received the 25M MPC dose showed a significant 8.9 point improvement in ejection fraction over controls at 3 months (p=0.008), with a sustained but less pronounced effect over 12 months. In contrast, the group who received 150M MPC did not show improved ejection fraction, suggesting that the positive effects of this dose on clinical outcomes, remodeling, and functional capacity may be due to other mechanisms such as anti-fibrosis.

"These clinical findings are the first using any cell therapy in heart failure patients to show a concordant positive effect on clinical outcomes, cardiac remodelling, and functional capacity, the three key parameters in congestive heart failure.  Together, they indicate that a single 150 million dose of Revascor™ may significantly reduce both heart failure hospitalizations and death in these very sick patients who have such a poor prognosis despite maximal existing therapies," Dr Perin said.  

"Based on their defined product characterization, batch to batch consistency, immediate availability, and lack of clinically relevant immunogenicity, MPCs appear to be an ideal cell type to provide a new level of patient care in congestive heart failure.  We look forward to progressing the Revascor™ clinical program into Phase 3," Dr Perin added.

Revascor™ is being jointly developed by Mesoblast and its strategic alliance partner, Teva Pharmaceutical Industries Ltd.  

Teva's Corporate Vice President Global Branded Products, Kevin Buchi, said: "These independently-reviewed results serve to reinforce Teva's commi
'/>"/>

SOURCE Mesoblast
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Positive Data for Nektars New Mu-Opioid Analgesic Molecule to Treat Acute Pain Highlighted at Neuroscience 2011
2. Ampio Pharmaceuticals Announces Positive Results on Ampion™ Trial for Relief of Nasal Inflammation
3. Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
4. Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease
5. NeuroDerm Announces Positive Results of a Phase II Study of ND0611 Dermal Patch in Patients with Parkinsons Disease
6. Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System
7. Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheims Two Investigational HCV Direct Acting Antivirals Presented at AASLD
8. Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial
9. Positive Phase 2b Results with Sarilumab in Rheumatoid Arthritis to be Presented as a Late-Breaking Poster at the 2011 American College of Rheumatology Annual Meeting
10. Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe
11. Halozyme Announces Positive Results from Roches Subcutaneous Herceptin Phase 3 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  Surgical Theater, ... members to its Business Advisory Board. New members ... Vice President for Business Development and New Technologies ... Fulton , former Senior Vice President and General ... Surgical Theater applies flight simulation technology to brain ...
(Date:7/28/2014)... , July 28, 2014  UBM Medica US ... leading online community for medical imaging professionals, explored the ... value-based payment models . The shift from ... how the radiologist,s reimbursement is determined in the ... insight from leaders in the field, who recognized the ...
(Date:7/28/2014)... 2014  A prospective study conducted by the ... has validated the performance of VolparaDensity breast imaging ... volumetrically assessed breast density measurements to breast cancer ... Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), the article, "Automated measurement ... breast cancer risk assessment," was authored by ...
Breaking Medicine Technology:Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 2Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 3Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 4Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 5Diagnostic Imaging Delves into Measuring the Radiologist's Value 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4
... 19, 2011 Reportlinker.com announces that a ... its catalogue: European Medical ... This research service examines ... terms of the challenges faced by market ...
... July 19, 2011 Data were presented today from ... including data from a 32 week follow-up period after ... gamma secretase inhibitor that had been studied as a ... patient outcomes from the active treatment portion of the ...
Cached Medicine Technology:European Medical Displays Markets 2European Medical Displays Markets 3European Medical Displays Markets 4Lilly Presents Follow-Up Data on Semagacestat to Assist Future Alzheimer's Disease Research 2Lilly Presents Follow-Up Data on Semagacestat to Assist Future Alzheimer's Disease Research 3Lilly Presents Follow-Up Data on Semagacestat to Assist Future Alzheimer's Disease Research 4
(Date:7/28/2014)... Dotinga HealthDay Reporter MONDAY, ... humans just milliseconds to look at someone,s face and judge ... finds that certain facial features seem to trigger specific first ... size of the mouth, for example, appear directly linked to ... attractiveness. The study findings suggest that first impressions ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Ticket Down ... AS Roma tickets in Dallas, TX at the Cotton ... 24th in the USA and it is an eight team ... around the world including teams from La Liga, Serie A, ... that will battle it out on the pitch include: ...
(Date:7/28/2014)... NY (PRWEB) July 28, 2014 Glutamine ... body and it’s considered to be conditionally essential during ... and is an advanced recovery & Immune System Support. ... the glutamine your body produces, supplementing with additional glutamine ... of waste products in the body, digestion and immune ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July ... are at risk of contracting meningitis because of specific ... to updated recommendations from the largest pediatrician group in ... the potentially deadly infection should continue for adolescents and ... In its first statement on meningococcal vaccines since 2011, ...
(Date:7/28/2014)... 2014 (HealthDay News) -- Endurance runners are far more ... heart condition, according to a new study. ... events in warm climates are actually 10 times more ... the less common sudden death of a young and ... as an irregular heartbeat, often gets a lot more ...
Breaking Medicine News(10 mins):Health News:Facial Dimensions May Be Key to First Impressions 2Health News:Facial Dimensions May Be Key to First Impressions 3Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 3Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 3Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 2Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 3Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2
... with Frequently ... Misdiagnosed Condition, WASHINGTON, ... (IC) Awareness Day, the National Association of Nurse,Practitioners in Women,s ... released the results of the first survey of IC,patients highlighting ...
... Funding will Accelerate Expansion of Industry Leading Health and Human ... Services On-Demand Software Solutions, ... the industry-leading provider of software solutions for the,health and human ... equity and debt financing totaling $28 million. The round was ...
... seasonal * Online advertised vacancies are ... the year gains in advertised ... vacancies, * ... 31 In October there were 4,161,700,online advertised vacancies, a decrease of 108,300 ...
... even Alzheimer,s, experts say , , WEDNESDAY, Oct. 31 (HealthDay News) ... brain,s own stem cells may have the ability to restore ... by protecting existing cells and promoting neuronal connections. , In ... were able to bring the rodents, memory back to healthy ...
... seventh leading cause of cancer death worldwide, the occurrence ... and gender. Esophageal cancer is thought to be triggered ... the host genome. Researchers have long been seeking the ... on gene-environment interaction and gene polymorphisms for esophageal cancer. ...
... undertaking elective surgery to remove part or all of the ... be too high, warn researchers in a study published on ... term for chronic inflammation of the intestine and includes ulcerative ... people in the UK are affected and many people will ...
Cached Medicine News:Health News:October 31 is National Interstitial Cystitis (IC) Awareness Day 2Health News:October 31 is National Interstitial Cystitis (IC) Awareness Day 3Health News:October 31 is National Interstitial Cystitis (IC) Awareness Day 4Health News:Harmony Information Systems Raises $28 Million in Series B Financing from JMI Equity, Updata Partners, ORIX Venture Finance and Comerica Bank 2Health News:Harmony Information Systems Raises $28 Million in Series B Financing from JMI Equity, Updata Partners, ORIX Venture Finance and Comerica Bank 3Health News:Harmony Information Systems Raises $28 Million in Series B Financing from JMI Equity, Updata Partners, ORIX Venture Finance and Comerica Bank 4Health News:Online Advertised Job Vacancies Dip in October, The Conference Board Reports Today 2Health News:Online Advertised Job Vacancies Dip in October, The Conference Board Reports Today 3Health News:Online Advertised Job Vacancies Dip in October, The Conference Board Reports Today 4Health News:Online Advertised Job Vacancies Dip in October, The Conference Board Reports Today 5Health News:Online Advertised Job Vacancies Dip in October, The Conference Board Reports Today 6Health News:Stem Cells Restore Memory in Mice 2Health News:Stem Cells Restore Memory in Mice 3Health News:ADH2 and ALDH2 are associated with esophageal cancer 2Health News:Threshold for bowel surgery may be too high, warn experts 2
... new Finnpipette Focus from Thermo ... combine ergonomics with uncompromising performance. ... plate offers a custom fit ... new shorter tip cones allow ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Inquire...
... precision, ergonomics, and value!, Comfortable ... soft non-slip, contoured handle , Finer ... plunger spring action , Completely autoclavable ... the need for recalibration , Easy-to-read ...
Medicine Products: